GLP-1 Drugs Impact
The discussion highlights the profound potential of GLP-1 weight loss drugs on the obesity economy, projected at $1.7 trillion. While current access seems limited to affluent individuals, there's optimism for broader availability as innovation and government involvement may eventually expand access to those who need it most. The conversation also touches on the implications for major food corporations as obesity rates decline.In this clip
From this podcast
The Prof G Pod with Scott Galloway
Prof G Markets: Breaking Down 2024 Predictions + Audience Comments and Pushback
Related Questions